Caroline Watson, MD
Ophthalmology · Huntsville, ALNPI 1144756875
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 31.0% of the total. 2025 is the largest year on record at $135,814, more than ten times the $4,890 reported in 2021. Among ophthalmology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 459 payments — averaging $636.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$90K
- Bausch & Lomb Americas Inc.$42K
- Johnson & Johnson Surgical Vision, Inc.$40K
- Alcon$30K
- Biotissue Holdings Inc.$28K
- Dompe US, Inc.$17K
- plus $44K from 20 others
Across 1 payment — averaging $9.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$9
What the payments were for
- Consulting fees$162,33156%
- Speaking & faculty fees$80,88128%
- Travel & lodging$26,2649%
- Food & beverage$18,0776%
- Education$3,4001%
- Other$1,3560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 77 | $90,483 |
| Bausch & Lomb Americas Inc. | 64 | $42,296 |
| Johnson & Johnson Surgical Vision, Inc. | 54 | $39,956 |
| Alcon | 67 | $30,351 |
| Biotissue Holdings Inc. | 38 | $28,355 |
| Dompe US, Inc. | 16 | $16,761 |
| Alcon Research LLC | 7 | $11,063 |
| Rxsight Inc | 10 | $8,361 |
| Sight Sciences, Inc. | 16 | $6,272 |
| Beaver-visitec International, Inc. | 3 | $3,505 |
| Carl Zeiss Meditec, Inc. | 8 | $2,988 |
| Carl Zeiss Meditec USA, Inc. | 28 | $2,344 |
| Lensar, Inc. | 18 | $2,227 |
| Nordic Pharma, Inc. | 1 | $2,100 |
| AbbVie | 13 | $1,570 |
| Rayner Intraocular Lenses Limited | 2 | $1,289 |
| Glaukos Corporation | 12 | $770 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $409 |
| NEW World Medical,inc. | 3 | $353 |
| Lumenis BE Inc | 1 | $321 |
| Ivantis, Inc | 2 | $249 |
| Sun Pharmaceutical Industries Inc. | 6 | $142 |
| Johnson & Johnson Vision Care, Inc. | 1 | $56 |
| Tearlab Corp | 1 | $55 |
| Eyevance Pharmaceuticals LLC | 1 | $21 |
| Iridex Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$79,903
- IFS ADVANCED FEMTOSEC LASER$30,448
- enVista MX60 IOL$20,618
- STELLARIS ELITE$17,692
- Oxervate$16,597
- Crystalens Accommodating IOL (AT-52AO)$16,031
- Trulign IOL$16,031
- Clareon$11,976
- NGENUITY$10,740
- Prokera$10,342
- Tecnis Simplicity$6,942
- OMNI(R) SURGICAL SYSTEM (US)$5,922
- SION SURGICAL INSTRUMENT$5,922
- AcrySof IQ PanOptix UV IOL$5,513
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$5,500
- AcrySof IQ VIVITY$3,413
- VisuMax$3,001
- RXSIGHT CONTACT LENS$2,704
- RXSIGHT INJECTOR CARTRIDGE$2,704
- RXSIGHT INJECTOR HANDPIECE$2,704
How this compares
$292,308 in reported general payments places this provider in the 95th percentile of 197 ophthalmology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 31 | $1,728,448 |
| XdemvyLotilaner | 84 | $155,545 |
| Prednisolone Acetate | 23 | $942 |
| ValacyclovirValacyclovir Hcl | 12 | $900 |
| Timolol Maleate | 21 | $407 |
| Latanoprost | 17 | $319 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 16 | $174 |
| Tobramycin | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $16,761 | $1,728,44831 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $90,483 | $155,54584 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 197 ophthalmology providers in Alabama.
Other ophthalmology in Huntsville
- Jonathan RamseyHuntsville$8K
- William MitchellHuntsville$8K
- Paul FrederickHuntsville$6K
- Robert FosterHuntsville$6K
- Patricia McCoyHuntsville$5K
- Robert StevensHuntsville$5K
- Walter HubickeyHuntsville$4K
- Bret FisherHomewood$545K
- Ronald GrossFairhope$143K
- Kristin BainsBirmingham$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.